您要查找的是不是:
- liver disease induced drug 药物性肝损害
- Fan JG, Fang JW, Lu YS, et al.Over-expression of adipogenic genes in the liver of rats with nonalcoholic fatty liver disease induced by high-fat diet. 范建高;方继伟;陆元善;等.;高脂饮食非酒精性脂肪性肝病大鼠肝脏成脂相关基因表达增强
- Over-expression of adipogenic genes in the liver of rats with nonalcoholic fatty liver disease induced by high-fat diet 高脂饮食非酒精性脂肪性肝病大鼠肝脏成脂相关基因表达增强
- Roles of leptin and stearoyl-CoA desaturase-1 in pathogenesis of nonalcoholic fatty liver disease induced by a fat-rich diet 瘦素及硬脂酰CoA去饱和酶-1在高脂饮食大鼠非酒精性脂肪肝发病中的作用
- Can present second liver disease see China? 中国现在的乙肝病能看好吗?
- Cure liver disease, ever victorious! 疗肝脏疾病,百战百胜!
- Can second liver disease infect others? 乙肝病会不会传染给别人?
- Not all kinds of liver disease are infectious. 并非所有的肝病都传染。
- It causes hepatitis A, an acute liver disease. 其导致甲型肝炎,一种急性肝病。
- Measuring the level of serum lepin in chronic liver disease. 慢性肝病血清瘦素水平测定。
- SPIO-enhanced MRI can asist to diagnose liver disease. SPIO强化MRI对肝内病变的良恶性鉴别诊断有一定的帮助。
- EPL is a safe and effective drug in the treatment of chronic liver diseases. 易善力注射液治疗慢性肝病疗效确切且安全可靠。
- Diagnostic criteria of nonalcoholic fatty liver disease. 非酒精性脂肪性肝病诊断标准。
- Conclusion:SPIO-enhanced MRI can asist to diagnose liver disease. 结论:SPIO强化MRI对肝内病变的良恶性鉴别诊断有一定的帮助。
- On Adverse Reaction and Disease Induced by Drug 药物不良反应与药源性疾病
- It is indicated that AIHA may be a multiple system disease induced by the abnormality of immune system, which results in RBC hemolysis. 认为AIHA可能是一种免疫紊乱导致以红细胞破坏为突出表现的多系统疾病。
- Objective To study the efficacy of gamma globulin in combinat ion with aspirin for prevention of coronary disease induced by Kawasaki disease. 目的观察丙种球蛋白联合阿司匹林在预防川畸病发生冠状动脉病变的作用。
- Pathogenesis, diagnosis and treatment of drug induced liver disease 药物性肝病的发病机制及诊治
- Drugs such as thiazolidinediones might be a useful strategy to specifically attenuate the vascular disease induced by visceral inflammatory fat. 药物如罗格列酮,作为一种有用的策略,可以明显的减弱内脏脂肪炎症反应引起的血管疾病。
- Analysis of the Relevant Factors of Nonalcoholic Fatty Liver Disease. 非酒精性脂肪性肝病相关因素分析。